WHO Chief Discusses Covaxin, Resumption of AstraZeneca Vaccine Supplies to Covax Facility with Mandaviya
WHO said the timeframe for its Emergency Use Listing procedure is dependent on how quickly a company producing the vaccine is able to provide the data required.